This means there are fungi, like yeast or mold, growing in your blood. It's a serious infection that can make you very sick, especially if you're not healthy or have recently had surgery.
Every report comes from a Lived member, sent anonymously.
Have you tried Diflucan (Fluconazole) for Fungemia?
Fungemia means that fungi are circulating in the bloodstream. In most cases the fungus is Candida, a yeast that normally lives harmlessly on the skin and in the gut. A Candida bloodstream infection has its own name, candidemia. Less often, other yeasts such as Cryptococcus, Trichosporon or Rhodotorula are responsible, mainly in people whose immune defenses are seriously weakened. Fungemia is a serious infection that almost always develops in people who are already ill, usually while they are in the hospital. It has no distinctive symptoms. The most common sign is a fever that persists or returns despite antibiotics, and it can progress to sepsis, the body's extreme response to an infection, which can cause dangerously low blood pressure and organ failure. Once in the blood, fungi can also settle elsewhere, including the eyes, heart valves and bones. Fungemia is very different from common yeast infections of the mouth, skin or vagina, which stay at the body's surface.
Fungemia usually starts when yeast already living on a person's skin or in their gut gets into the blood, or when it grows on a medical device. Central venous catheters (IV lines placed in a large vein, often left in for weeks) are a major route. Candida can coat the catheter in a biofilm, a sticky layer that shields it from the immune system and from medicines. Less often, contaminated IV fluids, equipment or hands introduce it. The main risk factors are long courses of broad-spectrum antibiotics, which clear out the bacteria that normally keep yeast in check; nutrition given by vein (total parenteral nutrition); abdominal surgery or a leak from the bowel; long stays in intensive care; kidney failure needing dialysis; and weakened immunity from chemotherapy, blood cancers or immune-suppressing medicines. Cancer is common in this group: between a third and a half of people with candidemia have one. Premature and very low birth weight babies in neonatal intensive care are also at higher risk. Most people with these risk factors never develop fungemia, but the chance rises as they add up.
Fungemia is confirmed by a blood culture, in which blood samples are placed in bottles and watched for growth. Candida usually takes two to three days to grow, and cultures can miss the infection: in studies they detect it, on average, less than half the time. Drawing more blood and more than one set of bottles improves the odds. Because of these limits, doctors sometimes start antifungal treatment on suspicion when a seriously ill person with several risk factors keeps getting worse. When a culture grows a yeast, the laboratory identifies the species and tests which drugs work against it (susceptibility testing). This matters because some species, including Candida auris and Candida glabrata, can resist common antifungals. Blood tests that detect fungal cell-wall material (beta-D-glucan) or fungal genetic material (PCR) can add supporting evidence, but they do not replace cultures, since they can be positive for other reasons. Once fungemia is found, cultures are repeated to show when the blood has cleared. The team also decides whether to look for spread: an eye examination through dilated pupils for people with vision symptoms or who cannot report them, such as those on a ventilator, and an ultrasound of the heart (echocardiogram) for people with artificial heart valves, long-term dialysis, injection drug use or cultures that stay positive.
Treatment has two parts that work together: antifungal medicine and removing the source. For candidemia, the usual first choice is an echinocandin, a class of intravenous antifungals that includes micafungin, caspofungin, anidulafungin and rezafungin (given once a week). Guidelines prefer them because they kill Candida, act against biofilms and are generally well tolerated. Delays in effective treatment are linked to higher death rates, so treatment often begins before every result is back. Once the person is stable, the blood has cleared and testing shows the yeast is susceptible, treatment is often switched after about five to seven days to fluconazole (Diflucan), an antifungal that can be taken as a pill. This shortens time on an IV and can shorten the hospital stay. Liposomal amphotericin B, an older intravenous antifungal, is mainly kept for resistant infections or when other drugs fail. Fungemia from less common yeasts is treated according to the species and its test results, since some resist the usual first choices. Removing the source matters as much as the drug. A central venous catheter is usually taken out promptly, typically within a day or two, especially when it is the likely source, because yeast living on it can keep reseeding the blood. Infected collections in the abdomen may need drainage or surgery. An infectious diseases specialist is often involved, and their input has been linked to better survival.
Fungemia is a serious illness, and the outlook depends largely on how sick the person was beforehand and how quickly effective treatment starts. In one large study of adults with candidemia, about 42% had died within 90 days, compared with 17% of similar hospital patients without it. Much of that risk reflects the illnesses that made the infection possible in the first place. For uncomplicated candidemia, treatment usually continues for at least 14 days after the first negative blood culture. People whose white blood cell counts are low from cancer treatment are usually treated at least until their counts recover. If the infection has reached the eyes, heart valves or bones, treatment lasts longer, often four to six weeks or more for an eye infection, and is planned around that complication. Recovery from fungemia often runs alongside recovery from whatever led to it, such as surgery or a stay in intensive care. After leaving the hospital, follow-up may include finishing a course of fluconazole pills, blood tests and, for some people, a repeat eye examination. People who still need a central line or nutrition by vein, or who face more chemotherapy or a transplant, remain at risk of another bloodstream infection. For selected high-risk groups, such as some bone marrow transplant recipients, doctors may prescribe antifungal medicine to prevent infection.
Fungemia is usually found in the hospital, where the care team is already watching for it. After discharge, or for anyone at ongoing risk (a central line, nutrition by vein at home, or chemotherapy that lowers white blood cell counts), tell the care team right away about a fever, chills or an infection that is not getting better. During or after treatment for candidemia, report new blurred vision, floaters, eye pain or loss of vision to the care team promptly, because Candida can infect the eye and an eye examination is needed. Seek emergency care for possible sepsis: confusion or disorientation, rapid breathing or a racing heart, shortness of breath, or clammy, sweaty skin, especially alongside a fever or feeling very cold.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fungemia is like, what's helped you, or ask the community a question.